key: cord-0799737-1hi1y548
authors: Kanmaniraja, Devaraju; Kurian, Jessica; Holder, Justin; Gunther, Molly Somberg; Chernyak, Victoria; Hsu, Kevin; Lee, Jimmy; Mcclelland, Andrew; Slasky, Shira E.; Le, Jenna; Ricci, Zina J.
title: Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children
date: 2021-06-24
journal: Clin Imaging
DOI: 10.1016/j.clinimag.2021.06.025
sha: 3cdd1257930b590e9f541d087a77cd5fd6e854ce
doc_id: 799737
cord_uid: 1hi1y548

The coronavirus disease 2019 (COVID -19) pandemic caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected almost every country in the world, resulting in severe morbidity, mortality and economic hardship, and altering the landscape of healthcare forever. Although primarily a pulmonary illness, it can affect multiple organ systems throughout the body, sometimes with devastating complications and long-term sequelae. As we move into the second year of this pandemic, a better understanding of the pathophysiology of the virus and the varied imaging findings of COVID-19 in the involved organs is crucial to better manage this complex multi-organ disease and to help improve overall survival. This manuscript provides a comprehensive overview of the pathophysiology of the virus along with a detailed and systematic imaging review of the extra-thoracic manifestation of COVID-19 with the exception of unique cardiothoracic features associated with multisystem inflammatory syndrome in children (MIS-C). In Part I, extra-thoracic manifestations of COVID-19 in the abdomen in adults and features of MIS-C will be reviewed. In Part II, manifestations of COVID-19 in the musculoskeletal, central nervous and vascular systems will be reviewed.

liver function tests (12) . In the only retrospective case-control study of 204 COVID-19 patients who underwent non-contrast chest CT scan, steatosis was found in 31.9% of cases and only 7.1% of controls (13) . Steatosis was based on a single ROI measurement in the right lobe with an attenuation value <= 40 HU. However, underlying risk factors for steatosis such as diabetes, obesity, hypertension and abnormal lipid profile, were not available to exclude preexisting conditions leading to steatosis. Finally, unlike in the spleen and kidney where infarcts are reported in COVID-19, hepatic infarction is not a distinct feature. This is likely due to the liver's unique dual blood supply.

On imaging the liver may be enlarged. On ultrasound, the liver of patients with abnormal liver function tests may be coarsened and/or increased in echogenicity ( Figures  1,2) . On CT scan, the liver may be hypoattenuated on non-contrast or contrast-enhanced exam due to steatosis (Figure 3 ). Periportal edema and heterogeneity of hepatic enhancement may be seen on contrast-enhanced CT or MRI due to parenchymal inflammation. On MRI, loss of signal on opposed-phase sequences ( Figure 4 ) may be seen due to steatosis and periportal edema may be conspicuous on T2-weighted images or on contrast-enhanced images (7, 8, 14) . Periportal lymphadenopathy, typical of chronic liver disease, is not reported in COVID-19 (8) . In patients with severe COVID-19 infection, ancillary manifestations of hepatic inflammation and injury, such as parenchymal attenuation changes and abscesses may be seen ( Figure 5 ).

Portal vein thrombosis is not common in COVID-19 with only few reported cases (15) (16) (17) (18) (19) . Its mechanism is likely multifactorial. Since ACE2 receptors are present on vascular endothelial cells, direct viral entry can incite coagulopathy (4) . The vascular endothelium can be damaged by inflammatory cytokines, although sepsis-induced coagulopathy and endothelial dysfunction may play a role, especially in patients who are critically ill (3,4). Adult respiratory distress syndrome (ARDS) and hypoxia can also trigger a generalized thrombotic state by increased blood viscosity and a transcriptionfactor signaling pathway (3). Many of those who have severe disease are afflicted with comorbidities such as obesity and malignancy, and critically ill patients are often immobile, all of which may increase thrombotic risk (3). Microthrombosis within hepatic parenchyma has also been described, with autopsy results revealing thrombosis within the central veins and hepatic sinusoids (7) .

On ultrasound, portal vein thrombosis appears as echogenic material within the vein, although it may be anechoic and undetectable in the early acute stages. Color Doppler images may show total or partial absence of flow in the vein. On contrastenhanced CT or MRI, portal vein thrombosis appears as non-enhancing filling defect within the main or intrahepatic branches ( Figure 6 ). Clots may be occlusive or nonocclusive and may expand the involved vein.

Biliary stasis is quite common in COVID-19, manifesting as gallbladder distention, gallbladder sludge and/or biliary ductal dilatation on imaging. In a retrospective study of 37 COVID-19 patients who underwent abdominal imaging, gallbladder sludge and distension were reported in 54% of patients who underwent right upper quadrant ultrasound (4) . Acalculous cholecystitis has been reported in patients with COVID-19, although it is unclear if this is due direct viral injury or due to the J o u r n a l P r e -p r o o f multiple confounding factors of general sepsis, prolonged parenteral nutrition, or systemic cytokine release (20) . SARS-CoV-2 RNA has been detected in the gallbladder wall (21) . There are reports of patients developing acalculous cholecystitis several weeks after mild COVID-19 infection, suggesting there may be residual gallbladder stasis or endothelial injury (20) . In a large retrospective study of 80 COVID-19 patients with positive findings on abdominal imaging, abnormalities of the gallbladder and biliary system were found in 25% of patients, including gallbladder findings in 15% and biliary ductal dilatation in 10% (14) . Gallbladder findings included distention (6.2%), mural edema (2.5%) and possible or definite acute cholecystitis (5%).

On imaging, biliary stasis may manifest as increased gallbladder distention (typically defined as >/=5cm) and sludge, and acalculous cholecystitis is suggested when there is superimposed gallbladder mural thickening and pericholecystic fluid (20) (Figure  7 ). Prolonged biliary stasis may obstruct the biliary tree and result in cholangitis. This is demonstrated on imaging as extrahepatic or intrahepatic biliary ductal dilatation, and increased biliary ductal mural thickening and enhancement ( Figure 8 ). Gallstones should be excluded on ultrasound, as choledocholithiasis is a more common cause of biliary infection.

The management of acute cholecystitis in COVID-19 patients is controversial. Intravenous antibiotics alone or with percutaneous cholecystostomy are advocated by many as a bridging agent to cholecystectomy (22) [ Figure 9 ]. Since it remains unknown the extent to which SARS-CoV-2 remains in the smoke generated by electrocautery (23) , some recommend conservative management (24) . Others advocate an individualized approach based on the severity of cholecystitis and available resources during the pandemic (25) .

Imaging plays a role in the diagnosis of cholecystitis as well as in the in detection of complications of percutaneous cholecystostomy. These complications include placement in the wrong site, catheter dislodgement, intraabdominal hemorrhage or bile leak. Fistulae to the liver can develop when catheters are left in for extended periods of time. In order to avoid potential cholecystostomy risks, some institutions offer surgery in COVID-19 patients as first-line therapy (24) .

Pancreatic involvement in COVID-19 is much less common than hepatic or biliary involvement, and may occur from direct viral injury or secondary to general inflammation and systemic illness. Pancreatic islet cells contain ACE2 receptors that may permit direct viral entry, while the host immune-mediated cytokine response can also incite pancreatic damage. In a study of 52 patients hospitalized for COVID-19 pneumonia, 9 (17%) had pancreatic injury defined as elevation of amylase or lipase with only one requiring mechanical ventilation. None had clinically severe pancreatitis (26) . In a larger study of hospitalized COVID-19 patients, almost 11% (13 of 121) had elevated pancreatic enzymes (6) . Only 1-2% of patients with mild viral illness had elevated pancreatic enzymes while almost 18% of patients with severe illness had elevated pancreatic enzymes. On CT scan, no patients had evidence of necrosis and only 7.5% (5 of 67) patients with severe illness had imaging evidence of pancreatitis described mainly as focal pancreatic enlargement or dilatation of the pancreatic duct. Although reported cases of pancreatic injury in COVID-19 tend to be mild, the role of pancreatitis in aggravating systemic inflammation, contributing to ARDS or leading to potential chronic pancreatitis later on remains unknown (6) . Recurrent acute pancreatitis has been reported several weeks after resolution of COVID-19 infection (27) . Finally, in two larger retrospective studies of abdominal imaging findings in hospitalized COVID-19 patients (4, 14) , only one patient had reported pancreatitis (4) .

Imaging findings of pancreatitis in COVID-19 patients mimic those in other settings, with CT demonstrating diffuse or focal pancreatic enlargement, decreased pancreatic attenuation due to edema, surrounding fat stranding and indistinct gland margins. MRI shows similar manifestations, with the gland appearing enlarged with poorly defined margins, and with edema and free fluid appearing bright on T2 weighted images (Figures 10,11 ).

Acute kidney injury (AKI) is a common complication of SARS-CoV-2 infection, seen in about one third of hospitalized COVID-19 patients (28) . Patients with AKI have a higher associated morbidity and mortality with one meta-analysis showing 77% of patients developing a more severe infection, 5% requiring renal replacement therapy and having an overall increased mortality rate of 50% (29) . Among the patients who developed AKI and survived, only a third recovered renal function at the time of discharge, and about a third of patients failed to recover to baseline even on subsequent follow-up (30) . In addition, patients with chronic renal disease are at a higher risk of developing severe upper respiratory infection and pneumonia following exposure to COVID-19, secondary to their inherent proinflammatory state and diminished immunity (2, 31).

The mechanism of kidney injury in COVID-19 is likely multifactorial. Both the increased expression of ACE2 receptors in the kidneys and certain genetic traits and polymorphism of renal ACE2 receptors enable SARS-CoV-2 binding and viral cell entry (32) . The pathogenesis of AKI involves both direct and indirect effects. The direct effect of the virus causes endothelial damage, inflammatory response, coagulopathy and complement activation while the indirect effects are sequelae of the systemic effects of multisystem involvement including hypovolemia, critical care interventions and organ crosstalk (32) . Organ crosstalk is a complex communication network between distant organs that communicate by signaling factors such as cytokines, growth factors and release of damage associated molecular patterns (DAMPs) from injured tissue. Histologic evaluation of COVID-19 patients has revealed varying types of injury including collapsing glomerulopathy, proximal tubular injury, microthrombi and microangiopathy (32) .

On ultrasound, the kidneys of COVID-19 patients with AKI typically demonstrate increased or heterogeneous parenchymal echogenicity, with possible loss of corticomedullary differentiation (7) [ Figure 12 ]. Involved kidneys typically have preserved cortical thickness, which helps differentiate them from those with chronic kidney disease. Additionally, a combination of nonspecific findings including increased renal parenchymal echogenicity, loss of corticomedullary differentiation, increased resistive indices and decreased color Doppler flow can be seen in COVID-19 patients with collapsing focal segmental glomerulosclerosis (33) .

On non-contrast CT, J o u r n a l P r e -p r o o f perinephric fat stranding and thickening of Gerota's fascia correlated with higher serum creatinine levels in patients with AKI, suggesting more severe inflammation and parenchymal injury (34) . Following the administration of contrast, geographic hypodense areas maybe observed in the periphery of the kidneys from hypoperfusion attributed to vasculopathy (35) [ Figure 13 ].

Increased urinary frequency has been reported in COVID-19 patients. It is believed that expression of ACE2 receptors in the urinary bladder, although not as high as the kidneys, predisposes patients to interstitial or hemorrhagic cystitis. It is unclear whether the receptors are expressed on the basal or luminal bladder surface. However, infection arises both from urine along the luminal surface and from blood via the basal surface (36). Viral RNA and inflammatory cytokines have been identified in the urine of COVID-19 patients (36-38). Additionally, endotheliitis may be a factor in local bladder inflammation (36).

Imaging findings include diffuse and irregular bladder wall thickening on ultrasound and diffuse thickening and enhancement of the bladder wall on CT, with adjacent perivesicular stranding (7, 39) [ Figure 14 ].

Thromboembolic solid organ events in COVID-19 patients can be arterial or venous in origin (40) (41) (42) (43) . In a retrospective study of 141 COVID-19 patients with abdominal pain, 18% had solid organ infarct and vascular thrombosis (14) . The mechanism of organ infarction in COVID-19 is likely multifactorial. There is a direct cytopathic effect of SARS-CoV-2 which results in a viral mediated platelet-dependent endothelial inflammation causing endothelial dysfunction and rise in proinflammatory cytokines, leading to an increase in tissue factor expression (40, 44, 45) . Hypoxia in COVID-19 patients causes increased blood viscosity and the resulting hypoxia inducible transcription factors promote thrombosis (2, 46, 47) . Additionally, hypercoagulability from increased levels of coagulation factors and antiphospholipid antibodies along with decreased levels of anticoagulation proteins contribute to the increased incidence of thrombotic events in COVID-19 patients (48) . In a study of 82 patients with COVID-19 who underwent imaging, nine patients (11%) had thromboembolic findings, four of which were solid organ insults (19) . Three splenic and one renal infarct were identified with patent vasculature on contrast-enhanced CT. One additional case of renal vein thrombus was reported without reported renal infarct. This supports disseminated microvascular thrombosis in the etiology of solid organ infarction (19) .

Although relatively uncommon, renal infarcts have been reported in COVID-19 patients (40, 49) . Based on a retrospective study of 141 COVID-19 patients with abdominal symptoms, the incidence of renal infarct was 5% on CT scans (14) .

On ultrasound, renal infarcts appear as wedge shaped heterogeneous hypoechoic areas with decreased or absent perfusion on color Doppler images (7) . On CT and MRI, renal infarcts may appear as geographic focal or multifocal areas of diminished or absent parenchymal enhancement in one or both kidneys. The renal defects are typically wedgeshaped spanning the cortex and medulla with their apex towards the hilum and extending to the renal capsule. Several days after acute onset they typically have overlying thin capsular enhancement ("rim sign") due to preserved collateral capsular perfusion. Segmental infarcts have a characteristic geographic appearance that follows the distribution of the anterior and posterior branch vessels of the renal artery (50) . On MRI, infarcts vary with age and are usually hypointense on T1-weighted and T2-weighted images acutely, becoming higher in signal on T2-weighted images over the next few days as coagulation necrosis occurs. They may appear hyperintense on T1-weighted images if hemorrhage occurs. Healed or chronic infarcts have progressively decreased signal due to fibrosis and atrophy. There is often loss of normal corticomedullary differentiation in the infarcted segment and corresponding wedge-shaped areas of hypoennhancement on post contrast images (51) . Less commonly, a filling defect may be seen in the renal artery on post-contrast images [ Figure 15 ] or vein [ Figure 16 ].

Although relatively uncommon, splenic infarcts have been reported in COVID-19 patients. Based on a retrospective study of 141 COVID-19 patients with abdominal symptoms, the incidence of splenic infarct was 5% on CT scans (14) . In an autopsy series studying the spleens of 10 COVID-19 patients, one had splenic infarct (52) . In a case series of 3 patients with abdominal visceral infarction associated with severe COVID-19 infection, two had splenic infarcts (53) . One patient had both multifocal splenic infarcts and unilateral focal renal infarct and the other had small bowel necrosis and massive splenic infarction requiring surgery. Asymptomatic splenic infarct incidentally noted on CT scan performed for suspected pulmonary embolism has also been reported (54) .

On CT and MRI, splenic infarcts appear as single or multiple peripheral wedgeshaped hypoenhancing defects, with their apex pointed towards the hilum [ Figure 17 ]. They can also be rounded or linear in shape. Their appearance varies with age, being vague hypodense areas on CT with mottled enhancement in the first 24 hours, and becoming progressively better defined non-enhancing hypodense defects over the next week (55) . On MRI, splenic infarcts are typically hypointense on T1-and T2-weighted images without enhancement on the post contrast images. However, their appearance varies based on the presence of hemorrhage and with their age. Acute and hemorrhagic infarcts are hyperintense on T1-weighted images and hypointense on T2-weighted images. Subacute infarcts have fluid signal. Chronic infarcts may fully resolve or become hypointense on T2 and T2-weighted images. (56, 57) . Less commonly, a filling defect may be seen in the splenic vein or artery on post-contrast images [ Figure 18 ].

The mechanism of SARS-CoV-2 induced gastrointestinal symptoms is not fully understood and may in part be due to direct viral entry into enterocytes. A single-cell transcriptomic study of enteric and lung cells determined that co-expression of ACE2 and TMPRSS2 cell receptors is necessary to permit SARS-CoV-2 entry. Co-expression was found not only in the lung but also in the esophageal upper epithelial and gland cells, the ileum and colon (58) .

Gastrointestinal symptoms in COVID-19 are relatively frequent. In a large metaanalysis of 43 studies of gastrointestinal manifestations of COVID-19 including over 18,000 patients, diarrhea was the most common GI symptom (11.5%), followed by nausea and vomiting (6.3%), and abdominal pain (2.3%) (59) . Among symptomatic patients, 17.5% had severe COVID-19 illness and 9.8% had a milder illness. In a retrospective study of 141 patients with severe COVID-19 in the ICU, 45% had gastrointestinal symptoms on admission including abdominal pain, diarrhea and vomiting (60) . In a meta-analysis of 36 studies reporting abdominal imaging in COVID-19, 16% of patients presented solely with gastrointestinal symptoms (61) .

Gastrointestinal symptoms in COVID-19 may be due to hepatobiliary or enteric involvement and, in some, may be due to side effects of drug therapy or advanced sepsis. In addition, when enteric involvement occurs, the mechanism of bowel disease remains unclear with postulations including cytokine storm and inflammation, edema, or ischemia (61) . Further studies are needed to determine if there is a direct correlation between viral entry into enterocytes and imaging findings of enteritis or colitis, as mild cases are managed without operative intervention or definitive tissue diagnosis. The origin of bowel involvement in mild cases is therefore unknown and may be infectious, ischemic or due to an alternative cause.

Finally, it has also been reported that many patients with abdominal complaints lack abdominal imaging findings. In a study of abdominal CT scans of 23 patients whose lung bases had findings typical of COVID-19 and presented with abdominal complaints, there were no bowel abnormalities detected (62) . In a larger study of abdominal CT scans of hospitalized patients with COVID-19, 43% lacked abdominal imaging findings (14) . Of those who lacked abdominal findings in the study, 64% had basilar lung findings on CT. In another study of 43 hospitalized COVID-19 patients who underwent CT for abdominal complaints, 63% had no abdominal abnormality (63) . Therefore, it is not clear how often COVID-19 patients have relevant bowel involvement when symptomatic. Since abdominal symptoms are common, it can be postulated that some cases are due to nonspecific viral-induced pain or referred symptoms from basilar pneumonia.

The most common and consistently reported imaging manifestations of COVID-19 affecting the bowel include mural thickening, non-specific ileus, fluid-filled colon, and pneumatosis intestinalis. Portal vein gas and pneumoperitoneum are less commonly seen (61, 64) . In a retrospective review of 141 COVID-19 patients in the ICU, 56% had clinically or radiologically diagnosed ileus, 2% had Ogilvie-like syndrome, 4% had bowel ischemia (3% small bowel, 1% small and large bowel and 1% cecal), 11% had GI bleeding and 4% had Clostridium difficile colitis (60) . Out of 81 hospitalized COVID-19 patients who underwent abdominal CT, 24% had intestinal findings of which colorectal thickening (5%), small bowel thickening (12%), and ileus (18%) were the most common, while pneumatosis (1%) and perforation (1%) were relatively rare (64) .

In a retrospective study of 42 hospitalized COVID-19 patients who underwent CT, 31% had bowel wall abnormality (4). Small bowel thickening was reported in 12%, all of who were in the ICU. Colonic or rectal thickening was reported in 17%, of which nearly half were in the ICU. In another larger retrospective study of hospitalized COVID-19 patients who underwent CT for abdominal symptoms, 57% had positive abdominal imaging findings (14) . Bowel wall thickening was found at a lower rate of 15%, including mostly colonic and small bowel, with rare cases of esophageal and gastric thickening. An even smaller rate of bowel abnormalities was reported in a retrospective study of 32 hospitalized COVID-19 patients who underwent CT, where only 7% had nonspecific enteritis, with pneumatosis intestinalis in one patient (63) .

Colonic mural thickening on CT has been reported in a patient with symptomatic colitis in COVID-19 including one patient with hemorrhagic colitis confirmed on colonoscopy (65, 66) . Mucosal hyperenhancement and mural thickening of the colon, mild mesenteric vascular congestion and small adjacent lymph nodes have been reported on CT in patients with colitis (67) .

Finally, Horvat et al found the presence of intestinal findings on CT in hospitalized COVID-19 patients positively correlated with a higher risk of worse clinical outcome including death or assisted ventilation (64) .

Ileus can manifest as gaseous distention of the small bowel, colon or both and is relatively common in hospitalized COVID-19 patients ( Figure 19 ). Kaafarani et al. reported that 56% of patients in their case series of 141 patients with severe COVID-19 requiring ICU care had a clinical or radiographic diagnosis of ileus (60) . The pathophysiology of ileus in COVID-19 is likely multifactorial. In severely ill COVID-19 patients, ileus is commonly caused by metabolic and/or electrolyte derangements but may also be reactive to other complications of COVID-19 (60, 68) or due to direct viral entry into enterocytes with resultant intestinal inflammation and ensuing ileus (68) . A few cases of severe colonic ileus have been reported in patients with severe pulmonary COVID-19 infection (68, 69) , some of which were complicated by bowel ischemia (68, 69) and some of which were indistinguishable from Ogilvie syndrome (69) .

Acute mesenteric ischemia is a serious and not uncommon complication of COVID-19 infection with a high mortality. It is theorized to occur secondary to viralinduced hypercoagulability or thromboinflammation leading to thrombosis, as opposed to direct viral infection of the gastrointenstinal tract (70, 71) . Patients with mesenteric ischemia classically present with pain out of proportion to their physical exam and other gastrointestinal symptoms such as vomiting and diarrhea (71) . It is surmised that mucosal bowel ischemia expedites viral spread from the bowel wall leading to more rapid clinical deterioration because of the sudden increase in viral load (72) . If COVID-19 patients present with suspicious symptoms, there should be a low threshold to initiate a search for acute mesenteric ischemia with CT angiogram of the abdomen and pelvis.

Acute mesenteric ischemia can be caused by thromboembolic arterial or venous occlusion of medium or large mesenteric vessels or by microthrombosis of small vessels. A systematic literature review of studies reporting mesenteric ischemia in COVID-19 patients who had at least one gastrointestinal finding on imaging, defined as mesenteric arterial or venous thromboembolism or signs of small bowel ischemia, yielded 22 studies and 31 patients (73) . Nine (29%) had superior mesenteric arterial thromboembolism, 6 (19%) had occlusive thrombosis of the portal system or superior mesenteric vein and 16 (52%) had no visible vascular occlusion. More than two-thirds (64%) of all patients required laparotomy and bowel resection. The overall mortality was 39%. In this metaanalysis, almost half of patients with bowel ischemia had macrovascular arterial/venous thrombosis and half did not.

Imaging findings of COVID-19 related bowel ischemia on CT angiogram of the abdomen and pelvis are not unique and include mural thickening, a targetoid mural enhancement pattern, absent or diminished mural enhancement, mural hyperenhancement, ileus [ Figure 20 ], mesenteric vascular engorgement, mesenteric fat J o u r n a l P r e -p r o o f stranding and ascites. Pneumatosis and/or portomesenteric venous gas may reflect ischemia or infarction, but when seen together typically indicate infarction (74, 75) [ Figure 21 ]. Arterial filling defects or zones of vascular narrowing may occur in arterial ischemia with preservation or thinning of bowel wall thickness. Venous filling defects may occur in venous ischemia typically with associated mesenteric venous engorgement, mural thickening and ascites. In nonocclusive mesenteric ischemia, bowel wall may be normal or thickened due to reperfusion. Mesenteric fat stranding and ascites are also common (74) .

A few CT imaging reports of mesenteric ischemia in COVID-19 with confirmed bowel necrosis on surgical intervention have been reported. These include one case of non-enhancing distal ileal loops with adjacent free air and patent mesenteric vessels (76) and two cases of small bowel pneumatosis or portal venous gas suggestive of ischemia (4) . All three patients were reported to have yellow discoloration of the necrotic bowel on surgical exploration (4,76). The first patient had unsalvageable necrotic bowel from the ligament of Treitz to the transverse colon and died shortly after surgery with presumed microvascular thrombosis (76) . One of the other two patients underwent small bowel resection, revealing patchy necrosis ranging from mucosal to full-thickness necrosis with submucosal arteriolar microthomboses (4).

Finally, pneumatosis or portal venous gas is reported in COVID-19 patients with bowel ischemia in up to 20% (4 of 20) of ICU patients, and is typically considered a marker for possible mesenteric ischemia (4) . However, in the absence of clinical symptomatology, like in non-COVID-19 patients, it may not on its own indicate ischemia or mandate surgical intervention. Meini et al report a patient hospitalized for COVID-19 pneumonia that was successfully managed conservatively for asymptomatic intraperitoneal air bubbles and pneumatosis of the cecum and ascending colon noticed on chest CT performed for pulmonary embolism (77) . The etiology was theorized to be bowel wall injury and gut flora impairment during SARS-CoV-2 infection.

Ischemic colitis has been reported rarely in patients hospitalized with COVID-19 illness with bloody diarrhea. In one case it was attributed to shock and hemodynamic compromise triggered by small vessel vasoconstriction and mesenteric hypoperfusion (78) and in the other to inflammatory cytokine storm in a patient with risk factors for ischemic colitis but without hemodynamic compromise (79) .

Pneumoperitoneum in hospitalized COVID-19 patients has many causes including recent surgery, iatrogenic procedural trauma, bowel perforation, ischemia, and benign causes such as barotrauma in ventilated patients. Benign pneumomediastinum and pneumoperitoneum can be due to pulmonary interstitial emphysema, known as the Macklin effect (80) . In the setting of barotrauma, typically due to invasive mechanical ventilation, alveoli can rupture leading to small pockets of air tracking along the peribronchovascular sheaths into the mediastinum. Once air collects within the mediastinum, it can dissect into the peritoneal cavity, causing pneumoperitoneum via major diaphragmatic portals [ Figure 22 ]. Alternatively, even if pneumomediastinum is absent, air can track directly through pleural or diaphragmatic defects leading to isolated J o u r n a l P r e -p r o o f pneumoperitoneum (81) . Duarte et al. report a case of pneumoperitoneum in a hospitalized COVID-19 patient who developed pulmonary interstitial edema from nasal cannula oxygen supplementation leading to benign pneumoperitoneum (81) . Intrathoracic barotrauma has been reported in 15% of COVID-19 patients on assisted mechanical ventilation and is more likely to occur in younger patients (82) .

When unexpected pneumoperitoneum is detected in a COVID-19 patient on chest radiograph or abdominal imaging, it is essential to rule out potential bowel perforation or ischemia. If no cause is determined on abdominal CT, the patient should be observed closely to ensure bowel perforation or ischemia was not missed, and that the pneumoperitoneum is regressing. Given the high morbidity and mortality associated with exploratory laparotomy in hospitalized COVID-19 patients, there should be a high threshold for surgical intervention (81) . In certain situations, if a chest CT is performed, the Macklin effect can be confirmed by visualizing thin linear collections of air tracking along the bronchovascular sheath.

Although the exact incidence of GI bleeding in COVID-19 is unknown, GI bleeding is not uncommonly observed in hospitalized COVID-19 patients, and in some cases may be the primary indication for abdominopelvic CT scan. In one retrospective study, 5% of hospitalized COVID-19 patients had GI bleeding as the indication for abdominal CT (4) . Patients may also present with symptoms of perforated gastric or duodenal ulcers, which has been attributed to stress-related mucosal damage in the setting of severe illness or anticoagulation, rather than direct infection or ischemia of the gastrointestinal tract (83) . In a large case series of 4,871 patients in Northern Italy, 23 patients developed upper GI bleeds (0.5%), 78% of whom were on anticoagulation at the time bleeding, including 44% on full dose anticoagulation (84) . While most patients in the case series developed bleeding during their hospital course, 26% of patients initially presented to the emergency room for GI bleeding and then tested positive for COVID-19 infection, suggesting that in some cases bleeding may be directly due to COVID-19 infection rather than stress-related mucosal damage or anticoagulation (84) .

A multicenter international study of 114 endoscopies performed on COVID-19 patients for acute GI bleeds, found that 25% of bleeds were caused by ulcers, 16% by erosive/ulcerative gastro-duodenopathy and 9% by petechial or hemorrhagic gastropathy (85) . Utilizing multivariate regression analysis, the authors found that ICU admission, pre-existing frailty, and extended hospitalization had no impact on the risk of a positive endoscopy finding (85) .

Dedicated CT angiogram with a GI bleeding protocol, including non-contrast, arterial and portal venous phase images can detect foci of active bleeding at a rate of 0.3-0.5 ml/min which is less sensitive than RBC scanning (0.1-0.5 mL/min) but more sensitive than fluoroscopic angiography (0.5-1.0 mL/min) (86) . Alternatively, on a dual energy scanner, images maybe acquired in the arterial and portal venous phase with reconstruction of a virtual non-contrast image set (86) . On non-contrast exam, luminal blood product is hyperdense with attenuations ranging from 30 to 45 HU when unclotted and from 45-70 HU when clotted (87, 88) . Active extravasation of contrast appears as an area of intraluminal enhancement on arterial phase images that changes shape and attenuation on portal venous phase (89 Artigas) . In patients with intermittent bleeding or in stable patients with elevated creatinine, a technetium 99m ( 99m Tc) nuclear medicine scan with a sulfur colloid or red blood cell pharmaceutical agent may be used as an alternative imaging modality. 99m Tc scintigraphy has a high sensitivity but poor anatomic localization of acute GI bleed (90) . CT angiogram has the added benefit of detecting free air prompting a search for perforated gastric or duodenal ulcer as a source of GI bleed [ Figure 23 ,24].

Clostridium difficile colitis is frequently seen in severely ill COVID-19 patients after treatment with broad-spectrum antibiotics, which were given frequently early on in the pandemic and are still routinely given to COVID-19 patients with severe sepsis. In addition to antibiotic use, direct infection of enterocytes by the SARS-CoV-2 virus may disrupt the gut microbiome, increasing a patient's susceptibility to gastrointestinal infection, including Clostridium difficile (91) . Elderly patients, especially those living in long-term care facilities, have both an increased risk of severe COVID-19 illness and baseline elevated rates of Clostridum difficile colonization. This confounds our understanding of the true impact of COVID-19 infection on the development of Clostridium difficile colitis (91) . In a retrospective clinical laboratory review of hospitalized patients with Clostridium difficile infection, 9 patients co-infected with COVID-19 were found, all of whom had severe COVID-19 illness and developed symptomatic Clostridium difficile colitis during their hospital course, all related to antibiotic administration (92) .

Pseudomembranous colitis should be suggested whenever abdominopelvic CT scan shows a pattern of long segment colitis [ Figure 25 ] most commonly involving the rectosigmoid but which can be also be segmental involving the right or transverse colon or pan-colonic in extent. It is characterized by a more extensive pattern of circumferential mural thickening than other causes of colitis, with low attenuation intramural edema, and associated features including the "accordion sign," the "target sign," pericolonic stranding and ascites. Mural thickening is marked with a reported mean of 15 mm (range 3-32 mm), and is often irregular and shaggy (93) .

Children with COVID-19 experience far less severe pulmonary disease than adults and account for only a minority of confirmed COVID-19 cases (2-8%) (94, 95) . Although the majority of symptomatic children with COVID-19 have a respiratory illness, gastrointestinal symptoms have been reported in 33-35% of cases, with vomiting, diarrhea and abdominal most common (96, 97) . This review will focus on the multifaceted post-infectious clinical and imaging manifestations of COVID-19 unique to children, coined multisystem inflammatory syndrome in children (MIS-C).

Although infected children tended to be only mildly symptomatic during the early months of the pandemic, by April and May of 2020, several medical centers in Europe and North America reported children with a multiorgan Kawasaki disease-like syndrome, consisting of fever and mucocutaneous rash, sometimes with features of toxic shock syndrome (98) (99) (100) . This syndrome was previously given various overlapping definitions, however as more cases subsequently arose around the globe, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have given J o u r n a l P r e -p r o o f this entity the preferred label of "Multisystem Inflammatory Syndrome in Children" (MIS-C) (101, 102) .

MIS-C is an acute febrile illness characterized by inflammation, gastrointestinal symptoms, and cardiac manifestations (103, 104) . Although SARS-CoV-2 is not definitively known to cause MIS-C, temporal occurrences to outbreaks in Europe and America are highly suggestive of a link, and some cases even occur in the presence of an acute respiratory infection (104, 105) . Some MIS-C patients test positive for SARS-CoV-2 IgM and IgG antibodies, rather than testing positive for the virus on RT-PCR, and a minority of patients have recorded COVID-19 symptoms a few weeks prior to onset of MIS-C (95, 103,106-108). These findings raise the possibility that MIS-C represents a post-infectious immune-mediated phenomenon, rather than an acute viral infection (95, 107, 109) .

While some features of MIS-C, such as fever, conjunctival injection, oropharyngeal erythema, and maculopapular rash, overlap with Kawasaki disease, the two syndromes appear to be separate entities (96, 104, 107) . MIS-C is characterized by various elevated inflammatory laboratory values (erythrocyte sedimentation rate, Creactive protein, procalcitonin, interleukin-6, lactate dehydrogenase, D-dimer, and lymphopenia), myocardial dysfunction (elevated troponins, elevated pro-B-type natriuretic peptide, depressed ejection fraction), hypotension, shock, and acute kidney injury (98, (108) (109) (110) (111) (112) . Kawasaki disease has lower rates of myocardial involvement than MIS-C, and is more frequently associated with coronary artery aneurysms. Kawasaki disease typically presents before 5 years of age, with the highest incidence of disease in Asia. In contrast, MIS-C usually occurs in older children and adolescents, and has not been reported in China or Japan.

Treatment of MIS-C is both supportive and directed, consisting of fluid resuscitation, vasopressors and ionotropic support, anticoagulation, intravenous immune globulin (IVIG), glucocorticoids, and other immunomodulatory and antiviral drugs (95, 98, 105, 106, 109, 110) . Critical cases may require mechanical ventilation or extracorporeal membrane oxygenation (ECMO). Despite the severity of MIS-C at initial presentation, short-term outcomes are favorable, with the majority of patients recovering between a few days up to two weeks (110, 113) .

The diagnosis of MIS-C is made on clinical grounds, and imaging in not routinely indicated. However, imaging may be requested to exclude other acute pathologies, and imaging abnormalities are associated with fulminant illness (104) . While the vast majority of MIS-C patients experience gastrointestinal symptoms, a wide-ranged incidence (5-70%) of respiratory symptoms has been reported (105, 106, 108, 109, 110, 112) . Although this review is focused on the extra-pulmonary manifestations of COVID-19, the cardiothoracic imaging findings of MIS-C will be included because the majority of MIS-C patients have pulmonary findings that are slightly different than those of routine COVID-19 pneumonia and may have associated cardiac sequelae.

The most common respiratory complaint in MIS-C is tachypnea, although some patients may progress to respiratory failure requiring mechanical ventilation, likely secondary to shock and cardiac dysfunction (106, 108, 110, 114) . While initial chest radiographs can be normal, as the disease progresses, common radiographic J o u r n a l P r e -p r o o f findings include bilateral diffuse airspace opacities with basilar predominance, peribronchial thickening or interstitial opacities, bilateral pleural effusions, and cardiomegaly (112, (114) (115) (116) (117) (Figure 26,27) . The pulmonary opacities tend to be hazy and symmetric, suggesting that they reflect pulmonary edema, ARDS, and/or third spacing. These phenomena may be secondary to cardiac dysfunction, the hyperinflammatory status of the patient, or possibly even the sequelae of aggressive fluid resuscitation (112, (116) (117) (118) . Although chest radiograph findings in MIS-C can overlap with acute COVID-19 pneumonia, COVID usually presents as non-diffuse peripheral or subpleural opacities without pleural effusions and MIS-C usually presents as diffuse opacities with lower lobe predominance with pleural effusions (112, 117) . It is interesting to note that patients with MIS-C may demonstrate abnormalities on chest radiographs even in the absence of lower respiratory tract symptoms (114, 117) .

Chest CT is not routinely performed in MIS-C, but may be indicated in patients with sepsis or suspected pulmonary embolism (114, 116) . The most common chest CT findings are bibasilar consolidation with atelectasis and bilateral pleural effusions, with diffuse ground-glass opacity, septal thickening, and mild hilar lymphadenopathy less common (114) (Figure 28 ).

Echocardiography is routinely performed at baseline and in follow-up of patients with MIS-C. The most common finding is depressed left ventricular ejection fraction, with other findings including valvular regurgitation and small pericardial effusion (110, 111, 119, 120) . Coronary artery ectasia or aneurysms have been seen in a minority of patients on echocardiogram and cardiac CT (111, 114, 121) . Postinfectious myocarditis characterized by diffuse myocardial edema and hyperemia without evidence of fibrosis on delayed gadolinium-enhanced images has been reported on cardiac MRI (122) .

While adult COVID-19 patients are vulnerable to vascular complications, it remains unclear whether children with SARS-CoV-2 infection have an increased risk of thrombosis (123) (124) (125) (126) (127) . Data on thrombotic complications in pediatric COVID-19 and MIS-C is limited, likely due to its low incidence, and currently published guidelines for thromboprophylaxis in children are extrapolated from the adult population. The highest reported rate of symptomatic imaging-confirmed thromboembolic disease (deep venous thrombosis or pulmonary embolism) in one multicenter registry of MIS-C was 7% (106) . It is thought that children with COVID-19 and/or MIS-C who experience hospital-associated thrombotic events have markedly elevated plasma D-dimer levels, or have one or more superimposed risk factors (e.g. prior history of venous thrombosis, indwelling central line, active malignancy, etc) (124, 126) . Imaging is not necessarily required prior to initiation of therapy if a thromboembolic event is suspected, but can be obtained at the time of discharge, in order to guide the length and intensity of the anticoagulation regimen (125) 

Since patients with MIS-C most commonly present with gastrointestinal symptoms, often mimicking acute appendicitis, abdominal imaging is sometimes obtained even prior to recognition of the MIS-C diagnosis (98, 114, 128) . Commonly reported findings on abdominal radiographs, ultrasound, and CT include an ileus bowel J o u r n a l P r e -p r o o f gas pattern, mild ascites, gallbladder wall thickening, gallbladder sludge, bowel wall thickening, mesenteric lymphadenopathy, mesenteric edema or inflammatory change, and urinary bladder wall thickening (114, 116, 117, 129) (Figures 29,30,31) . Bowel wall thickening, lymphadenopathy, and mesenteric changes can occur anywhere in the abdomen but are most commonly located in the right lower quadrant (130) (Figure 32) . A minority of patients has also demonstrated hepatosplenomegaly, splenic infarction, and increased renal echogenicity (114, 116, 131) . Acute hepatitis, defined as elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, was found in 43% of subjects in a single-center report, and may account for some of the abdominal ultrasound findings in MIS-C such as hepatomegaly, gallbladder wall thickening, and ascites (132) .

Of patients with MIS-C who have undergone brain imaging, MRI is usually normal, however there are isolated reports of cortical signal abnormalities, papilledema, and infarct (114, 117) . Cervical lymphadenopathy has also been reported (112, 117) .

The SARS-CoV-2 virus has many extrathoracic facets in adults with a host of abdominal manifestations increasingly recognized. MIS-C is a unique postinfectious manifestation in children that encompasses gastrointestinal symptoms most commonly, but also includes unique pulmonary and cardiac manifestation different than those of typical COVID-19 respiratory infection. It is important for radiologists to have a better understanding of the pathophysiology of this disease and incidence of its involvement in various organ systems, along with improved familiarity with the broad spectrum of imaging manifestations of COVID-19. This will improve our ability to more accurately search for and diagnose COVID-19 sequelae and hopefully better assist clinicians in managing this complex disease. As the long-term effects of COVID-19 continue to emerge, we must stay vigilant and closely watch and monitor patients for any future unexpected manifestations of this novel COVID-19 disease. Figures 1,2 (1) 40-year-old man with COVID-19 pneumonia and no known liver disease with increasing liver function tests. (1a) Sagittal gray-scale ultrasound image demonstrates increased liver echogenicity, consistent with steatosis without hepatomegaly. (1b) Sagittal gray-scale ultrasound image shows a normal gallbladder (arrow) and no biliary dilatation (not shown).

(2) 68-year-old woman with COVID pneumonia and newly elevated liver function tests. Sagittal gray-scale ultrasound image shows increased hepatic echogenicity with poor acoustic penetration and contrasting hypoechogenic appearance of the right kidney compatible with steatosis, without hepatomegaly. Gallbladder (not shown) is normal. 65-year-old woman with COVID-19 and elevated liver enzymes due to hepatic steatosis. (a) Axial non-enhanced CT image shows diffuse hypoattenuation of the liver whose attenuation was greater than 10 HU lower than the spleen. (b) Subsequent contrastenhanced CT images shows marked hypoattenuation of the liver whose attenuation was greater than 30 HU lower than the spleen. 77-year-old man with rising bilirubin, fever and abdominal pain, with concern for acalculous cholecystitis. Sagittal gray-scale ultrasound image shows gallbladder distension and sludge (arrow). Findings were attributed to biliary stasis and not acalculous cholecystitis due to lack of mural thickening, hyperemia and sonographic Murphy's sign. 69-year-old woman with history of hypertension, coronary artery disease and congestive heart failure presented to the Emergency Room with cough and chest tightness. She was diagnosed with COVID-19 pneumonia and found to have acute kidney injury. (a) Coronal contrast-enhanced CT image shows multiple wedge-shaped non-enhancing defects in the left kidney (arrowheads). Also seen is perinephric fat stranding around the right kidney with thickening of the adjacent Gerota's fascia (arrows). (b) A more anterior coronal contrast-enhanced CT image shows a focal hypodense filling defect in the proximal left renal artery (arrow) consistent with thrombus. Figure 16 71-year-old woman from a nursing home with history of dementia, schizophrenia and obstructive sleep apnea, found to be COVID-19 positive and presented to the Emergency Room unresponsive and with acute kidney injury. Axial contrast-enhanced CT image shows a hypodense filling defect distending the left renal vein consistent with nonocclusive renal vein thrombus (arrow). 69-year-old man with history of atrial fibrillation hospitalized with COVID-19 pneumonia that developed a cerebrovascular attack in the ICU and required intubation for respiratory compromise. Prior to PEG placement CT of the abdomen and pelvis was performed to assess his anatomy. Axial contrast-enhanced CT image demonstrates a large wedge-shaped non-enhancing splenic infarct (asterisk) and diffuse hypodense filling defect in the splenic artery (arrows) consistent with thrombus. Enhancing splenic vein is noted (arrowhead). The patient did not survive. Figure 19 72-year-old woman in the Emergency Room with weakness, nausea and abdominal pain who tested positive for SARS-CoV-2. Supine portable radiograph shows mild prominence of air-filled small bowel that is minimally distended and mild prominence of non-dilated segments of colon consistent with ileus. No further imaging was performed. The patient was treated conservatively with supportive therapy and discharged 3 days later. (b,c) Axial and coronal contrast-enhanced CT images show dilated proximal and mid small bowel loops (arrows) with non-distended distal small bowel and small amount of colonic air with no discrete transition zone. Findings are most suggestive of a severe ileus pattern, somewhat mimicking a small bowel obstruction. Exploratory laparotomy was performed revealing a friable mesentery with several areas of ecchymosis, dilated, hyperemic, thickened and dusky small bowel. The abdomen was left open. No obstruction was found and findings were deemed to be secondary to COVID-19 related ischemia. Re-exploration 10 days later revealed normal small bowel and resolution of ileus. The patient improved and was later discharged to rehabilitation center. gutter. Subcutaneous emphysema in the right axilla is noted (black asterisk). Bilateral pneumonia is noted and the nasogastric is partially visualized. Figure 23 73-year-old woman found collapsed in her home was brought to the Emergency Room for abdominal pain and shortness of breath due to COVID-19 pneumonia. Non-contrast CT scan of the chest, abdomen and pelvis revealed multifocal pneumonia in the lung bases (not shown), moderate upper abdominal pneumoperitoneum (arrows) and moderate ascites with mild mesenteric and subcutaneous edema. The underlying duodenal bulbar region (*) is surrounded by free air. Exploratory laparotomy revealed a 1 cm anterior bulbar perforation that was repaired. Figure 24 82-year-old woman with chronic obstructive pulmonary disease and end-stage renal disease sent from the nursing home 4 weeks after testing positive for COVID-19 with leukocytosis. (a) Axial contrast-enhanced CT image show a mildly thick-walled duodenal bulbar region (arrows) with a small anterior defect and extraluminal gas (arrowhead) consistent with locally perforated ulcer. Two small left renal cysts are present. (b) Coronal CT image shows a small walled off fluid collection with fluid and gas (arrowheads) in the adjacent right hepatic lobe at the level of the ulcer defect. Arrows indicate the thickened duodenal bulbar wall. Since the patient was not a candidate for surgical intervention she was treated conservatively with IV antibiotics. Figure 25 74-year-old morbidly obese woman with history of breast cancer and prolonged ICU hospitalization for severe COVID-19 pneumonia causing acute respiratory failure. One week after discharge to a nursing home, she was readmitted to the hospital for fever, hypotension and diarrhea. (a) Coronal non-contrast CT image with oral contrast shows prominent right and left colonic mural thickening (arrows) which involved the entire colon (not shown). (b) Axial image better shows the extent of mural thickening in the right colon (arrow) due to luminal contrast. Clostridium difficile infection was confirmed and she improved after treatment with oral Vancomycin and IV Flagyl. Her course was subsequently further complicated by gastrointestinal bleeding and retroperitoneal hemorrhage due to anticoagulation. (c) Axial non-contrast CT image shows hyperdense content expanding both psoas muscles (arrows), and in the right paracolic gutter (arrowhead).

Chest radiographs in two patients with MIS-C. (26) 9-year-old girl with previously healthy girl who presented with cardiogenic shock and acute renal failure. Frontal chest radiograph shows symmetric hazy airspace opacities, increased interstitial markings, and bilateral small pleural effusions. (27) 9-year-old boy with history of asthma, who presented with high fever, rash and abdominal pain. Frontal chest radiographs shows mild cardiomegaly and bilateral symmetric central consolidative airspace opacities. 8-year-old girl with MIS-C who presented with abdominal pain, diarrhea, fever, tachycardia and hypotension. Coronal contrast-enhanced CT image demonstrates a cluster of enlarged mesenteric lymph nodes in the right lower quadrant (arrows). There is diffuse mild fluid distention of small and large bowel consistent with ileus. Figure 31 13-year-old boy with MIS-C who presented with abdominal pain, vomiting, diarrhea, fever, hypotension and elevated liver function tests. (a) Coronal contrast-enhanced CT image demonstrates mural thickening of the ascending colon (arrows) and terminal ileum (TI). Gallbladder wall thickening is noted. (b) Coronal image in a more posterior location shows a chain of enlarged mesenteric lymph nodes (thin arrows), with hazy infiltration of the mesentery (arrowheads). There is also small pelvic ascites (thick arrows).

18-year-old man with MIS-C who presented with headache, right lower quadrant abdominal pain and elevated inflammatory markers. (a) Sagittal gray-scale ultrasound image of the right lower quadrant demonstrates wall thickening of the ascending colon and cecum (arrows). (b) Coronal contrast-enhanced CT image confirms moderate wall thickening of the right colon (arrows) and thickening of the terminal ileum (arrowhead).

 Hepatic parenchymal injury and biliary stasis are common in COVID-19 with steatosis, gallbladder distension and sludge common on imaging.  Acute kidney injury is seen in about one third of hospitalized COVID- 19 patients with increased or heterogeneous renal echogenicity seen on ultrasound and preserved cortical thickness.  Splenic and renal infarcts are reported in up to 5% on CT scans of COVID- 19 patients.  Ileus is the most commonly reported bowel abnormality in hospitalized COVID-19 patients.  Children with multisystem inflammatory syndrome most commonly present with gastrointestinal symptoms and less frequently with respiratory symptoms. 

Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications

Abdominal Imaging Findings in COVID-19: Preliminary Observations

Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetesassociated mortality, and disease recurrence in COVID-19 patients

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection

Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations

Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury

Liver injury in COVID-19: A minireview

High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and metaanalysis of autopsy data

Liver injury in COVID-19: management and challenges

Diagnostic value of abdominal sonography in confirmed COVID-19 intensive care patients

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients

Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19)

Portal vein thrombosis in a patient with COVID-19

Acute portal vein thrombosis secondary to COVID-19: a case report

MScBR 2 ; Novikov

Venugopal MD 3 Portal Vein Thrombosis in a Patient With COVID-19

Portal vein thrombosis associated with COVID-19: points to consider

Hypercoagulability in Patients With Coronavirus Disease (COVID-19): Identification of Arterial and Venous Thromboembolism in the Abdomen, Pelvis, and Lower Extremities

Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report

COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall

Percutaneous cholecystostomy instead of laparoscopy to treat acute cholecystitis during the COVID-19 pandemic period: single center experience

The role of cholecystostomy drains in the management of acute cholecystitis during the SARS-CoV-2 pandemic. What can we expect?

BRIEF Outline of Management of Symptomatic Gallbladder Disease and Acute Cholecystitis During the COVID -19 Pan Epidemic

Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia

Recurrent Acute Pancreatitis in a Patient with COVID-19 Infection

The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis

Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis

AKI in Hospitalized Patients with COVID-19

Kidney disease is associated with in-hospital death of patients with COVID-19

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

Renal ultrasound findings secondary to COVID-19 related collapsing focal segmental glomerulosclerosis -A case report

COVID-19 associated kidney impairment in adult: Qualitative and quantitative analyses with non-enhanced CT on admission

Acute reversible renal failure requiring temporary dialysis in a patient with COVID-19. Radiol Case Rep

COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC)

Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China

Endothelial cell infection and endotheliitis in COVID-19

Kidney Infarction in Patients With COVID-19

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

The Role of Inflammation in Venous Thromboembolism. Front Pediatr

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

The stimulation of thrombosis by hypoxia

Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19

Possible radiologic renal signs of COVID-19

Tailored helical CT evaluation of acute abdomen

Atypical low-signal-intensity renal parenchyma: causes and patterns

Abdominal Visceral Infarction in 3 Patients with COVID-19

2021) Incidental Asymptomatic Splenic Infarct in a COVID-19 Patient

CT patterns of splenic infarction: a clinical and experimental study

MRI of focal splenic lesions without and with dynamic gadolinium enhancement

Cystic masses of the spleen: radiologicpathologic correlation

Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process

COVID-19 gastrointestinal manifestations: a systematic review

Gastrointestinal Complications in Critically Ill Patients With COVID-19

Abdominal imaging findings in patients with SARS-CoV-2 infection: a scoping review

Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT

Abdominal CT in COVID-19 patients: incidence, indications, and findings

Abdominal gastrointestinal imaging findings on computed tomography in patients with COVID-19 and correlation with clinical outcomes

Computerized tomography scan findings of a patient with severe enterocolitis associated with the coronavirus disease 2019: a case report

SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease

Alaaeldin Abdelmajid, SARS-CoV-2 infection presenting as colitis with chest and abdomen CT findings

Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19

Paralytic ileus in Covid-19 Patients

Pneumatosis Intestinalis in COVID-19

Our early experience with mesenteric ischemia in COVID-19 positive patients

Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity

Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation

CT Diagnosis of Acute Mesenteric Ischemia from Various Causes

Pneumatosis intestinalis in patients with ischemia: correlation of CT findings with viability of the bowel

Bowel Necrosis in the Setting of COVID-19

Pneumatosis intestinalis in COVID-19

Case Report: Ischemic Colitis in Severe COVID-19 Pneumonia: An Unforeseen Gastrointestinal Complication

Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication

Malignant interstitial emphysema of the lungs and mediastinum as an important occult complication in many respiratory diseases and other con-ditions: interpretation of the clinical literature in the light of laboratory experiment

Pneumoperitoneum in a COVID-19 Patient Due to the Macklin Effect

Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation

Gastrointestinal perforation in a critically ill J o u r n a l P r e -p r o o f Journal Pre-proof patient with COVID-19 pneumonia

Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy

Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study

CT for Evaluation of Acute Gastrointestinal Bleeding

Multidetector CT evaluation of active extravasation in blunt abdominal and pelvic trauma patients

Blood in the belly: CT findings of hemoperitoneum

Multidetector CT angiography for acute gastrointestinal bleeding: technique and findings

Scintigraphic detection of acute gastrointestinal bleeding

Clostridioides difficile infection in the COVID-19 era: old and new problems

Clostridioides difficile in COVID-19 Patients

Pseudomembranous Colitis: Spectrum of Imaging Findings with Clinical and Pathologic Correlation

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations

Gastrointestinal Symptoms Prevalent in Both Children with MIS-C and those with COVID-19

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Hyperinflammatory shock in children during COVID-19 pandemic

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19

Multisystem Inflammatory Syndrome in Children in New York State

Multisystem Inflammatory Syndrome in Children: An International Survey

Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation

Tenfordesyndrome in pediatric COVID-19 patients: a meta-analysis

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

Distinguishing active pediatric COVID-19 pneumonia from MIS-C

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City

Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States

Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19

Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children

Spectrum of Imaging Findings at Chest Radiography, US, CT, and MRI in Multisystem Inflammatory Syndrome in Children Associated with COVID-19

Imaging of children with COVID-19: experience from a tertiary children's hospital in the United States

Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children

Imaging in support of the clinical diagnoses of COVID-19 and multisystem inflammatory syndrome in children

Multisystem inflammatory syndrome in children: A systematic review

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach

Cardiac MRI in Children with Multisystem Inflammatory Syndrome Associated with COVID-19

Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients

Pediatric/Neonatal and I. S. Thrombosis Subcommittee of the. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness

Antithrombotic prophylaxis in children and adolescents' patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians

COVID-19 anticoagulation recommendations in children

SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children

Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases

Features of Intestinal Disease Associated With COVID-Related Multisystem Inflammatory Syndrome in Children

Abdominal Imaging Findings in Critically Ill Children With Multisystem Inflammatory Syndrome Associated With COVID-19

Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center